Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 7,037 shares of the stock in a transaction on Wednesday, December 6th. The shares were sold at an average price of $4.82, for a total value of $33,918.34. Following the completion of the sale, the chairman now owns 1,537,543 shares in the company, […]
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 8,347 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $5.14, for a total transaction of $42,903.58. Following the completion of the sale, the chairman now owns 1,571,196 shares in the […]
Apart from the already existing players such as Pfizer, Sanofi, Taiho Pharma, Ono Pharma, along with others, there are several emerging key players, that are.
DelveInsight Business Research, LLP: Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period (2019-2032) finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Research Analysts’ updated eps estimates for Monday, November 13th: Aadi Bioscience (NASDAQ:AADI) had its price target reduced by HC Wainwright from $45.00 to $36.00. HC Wainwright currently has a buy rating on the stock. Annexon (NASDAQ:ANNX) had its price target trimmed by Needham & Company LLC from $24.00 to $16.00. They currently have a buy […]